Administration of A. muciniphila ameliorates pulmonary arterial hypertension by targeting miR-208a-3p/NOVA1 axis

被引:1
|
作者
Bao, Zheng-yi [1 ]
Li, Hui-min [2 ]
Zhang, Shuo-bo [1 ]
Fei, Yi-qiu [1 ]
Yao, Ming-fei [1 ,3 ]
Li, Lan-juan [1 ,3 ,4 ]
机构
[1] Zhejiang Univ, Sch Med,Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310000, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp,Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 201100, Peoples R China
[3] Chinese Acad Med Sci, Res Units Infect Dis & Microecol, Beijing 100010, Peoples R China
[4] Jinan Microecol Biomed Shandong Lab, Jinan 250000, Peoples R China
关键词
A; muciniphila; pulmonary arterial hypertension; MicroRNA; lung-gut axis; proliferation; GUT MICROBIOME; PROLIFERATION; METABOLOME; MIGRATION; PASMCS; GROWTH; CELLS;
D O I
10.1038/s41401-023-01126-2
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pulmonary arterial hypertension (PH) is a chronic disease induced by a progressive increase in pulmonary vascular resistance and failure of the right heart function. A number of studies show that the development of PH is closely related to the gut microbiota, and lung-gut axis might be a potential therapeutic target in the PH treatment. A. muciniphila has been reported to play a critical role in treating cardiovascular disorders. In this study we evaluated the therapeutic effects of A. muciniphila against hypoxia-induced PH and the underlying mechanisms. Mice were pretreated with A. muciniphila suspension (2 x 10(8) CFU in 200 & mu;L sterile anaerobic PBS, i.g.) every day for 3 weeks, and then exposed to hypoxia (9% O-2) for another 4 weeks to induce PH. We showed that A. muciniphila pretreatment significantly facilitated the restoration of the hemodynamics and structure of the cardiopulmonary system, reversed the pathological progression of hypoxia-induced PH. Moreover, A. muciniphila pretreatment significantly modulated the gut microbiota in hypoxia-induced PH mice. miRNA sequencing analysis reveals that miR-208a-3p, a commensal gut bacteria-regulated miRNA, was markedly downregulated in lung tissues exposed to hypoxia, which was restored by A. muciniphila pretreatment. We showed that transfection with miR-208a-3p mimic reversed hypoxia-induced abnormal proliferation of human pulmonary artery smooth muscle cells (hPASMCs) via regulating the cell cycle, whereas knockdown of miR-208a-3p abolished the beneficial effects of A. muciniphila pretreatment in hypoxia-induced PH mice. We demonstrated that miR-208a-3p bound to the 3 & PRIME;-untranslated region of NOVA1 mRNA; the expression of NOVA1 was upregulated in lung tissues exposed to hypoxia, which was reversed by A. muciniphila pretreatment. Furthermore, silencing of NOVA1 reversed hypoxia-induced abnormal proliferation of hPASMCs through cell cycle modulation. Our results demonstrate that A. muciniphila could modulate PH through the miR-208a-3p/NOVA1 axis, providing a new theoretical basis for PH treatment.
引用
收藏
页码:2201 / 2215
页数:15
相关论文
共 50 条
  • [1] Administration of A. muciniphila ameliorates pulmonary arterial hypertension by targeting miR-208a-3p/NOVA1 axis
    Zheng-yi Bao
    Hui-min Li
    Shuo-bo Zhang
    Yi-qiu Fei
    Ming-fei Yao
    Lan-juan Li
    Acta Pharmacologica Sinica, 2023, 44 : 2201 - 2215
  • [2] miR-208a-3p suppresses cell apoptosis by targeting PDCD4 in gastric cancer
    Yin, Kai
    Liu, Minghui
    Zhang, Mei
    Wang, Feng
    Fen, Min
    Liu, Zhijian
    Yuan, Yutao
    Gao, Shanting
    Yang, Liuqing
    Zhang, Weijie
    Zhang, Jianguo
    Guo, Baoliang
    Xu, Jianwei
    Liang, Hongwei
    Chen, Xi
    Guan, Wenxian
    ONCOTARGET, 2016, 7 (41) : 67321 - 67332
  • [3] miR-27-3p inhibition restore fibroblasts viability in diabetic wound by targeting NOVA1
    Zhang, Peng
    Song, Xiaomei
    Dong, Qirong
    Zhou, Long
    Wang, Lei
    AGING-US, 2020, 12 (13): : 12841 - 12849
  • [4] MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension
    Miao, Renying
    Liu, Wanli
    Qi, Chaoran
    Song, Yan
    Zhang, Yonggan
    Fu, Yiqun
    Liu, Weiping
    Lang, Yuchang
    Zhang, Yifei
    Zhang, Zhimin
    LIFE SCIENCES, 2020, 257
  • [5] miR-208a-3p Suppresses Osteoblast Differentiation and Inhibits Bone Formation by Targeting ACVR1
    Arfat, Yasir
    Basra, Muhammad Asim R.
    Shahzad, Muhammad
    Majeed, Kashif
    Mahmood, Nasir
    Munir, Hina
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 11 : 323 - 336
  • [6] Role of miR-223-3p in pulmonary arterial hypertension via targeting ITGB3 in the ECM pathway
    Liu, Aijun
    Liu, Yifan
    Li, Bin
    Yang, Ming
    Liu, Yang
    Su, Junwu
    CELL PROLIFERATION, 2019, 52 (02)
  • [7] MiR-582-5p inhibits the growth and invasion of osteosarcoma cell by targeting NOVA1
    Ye, C-Y
    Zheng, C-P
    Zhou, W-J
    Weng, S-S
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 11026 - 11031
  • [8] miR-181a/b-5p ameliorates inflammatory response in monocrotaline-induced pulmonary arterial hypertension by targeting endocan
    Zhao, Haiyan
    Guo, Yun
    Sun, Yue
    Zhang, Na
    Wang, Xiaofei
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (05) : 4422 - 4433
  • [9] MiR-193-3p attenuates the vascular remodeling in pulmonary arterial hypertension by targeting PAK4
    Wu, Zhenhua
    Geng, Jie
    Qi, Yujuan
    Li, Jian
    Bai, Yaobang
    Guo, Zhigang
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [10] miR-125a-5p inhibits glycolysis by targeting hexokinase-II to improve pulmonary arterial hypertension
    Luo, Li
    Xiao, Lusheng
    Lian, Guili
    Wang, Huajun
    Xie, Liangdi
    AGING-US, 2020, 12 (10): : 9014 - 9030